No evidence for taxane/platinum pharmacogenetic markers: just lack of power?

J Clin Oncol. 2008 Apr 10;26(11):1903-4; author reply 1904-5. doi: 10.1200/JCO.2007.15.7776.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bridged-Ring Compounds / administration & dosage
  • Carboplatin / administration & dosage
  • Cisplatin / administration & dosage
  • Clinical Trials as Topic
  • Female
  • Genetic Markers
  • Genotype
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics*
  • Polymorphism, Genetic
  • Research Design
  • Taxoids / administration & dosage
  • Treatment Outcome

Substances

  • Bridged-Ring Compounds
  • Genetic Markers
  • Taxoids
  • taxane
  • Carboplatin
  • Cisplatin